Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Risch

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Diagnostics (Basel, Switzerland)|August 23, 2020
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)Marc Kovac, Lorenz Risch, Sarah Thiel, et al.
Biomed Research International|November 23, 2020
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical PresentationMartin Risch, Myriam Weber, Sarah Thiel, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.
American Journal of Hypertension|February 27, 2018
Association of 24-Hour Blood Pressure With Urinary Sodium Excretion in Healthy AdultsJan Gerrit van der Stouwe, Cristian Carmeli, Stefanie Aeschbacher, et al.
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Disease Markers|February 3, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 AntibodiesMyriam C Weber, Martin Risch, Sarah L Thiel, et al.
Iscience|October 21, 2022
Genome-wide analyses identify <i>SCN5A</i> as a susceptibility locus for premature atrial contraction frequencySébastien Thériault, Medea Imboden, Mary L Biggs, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Genome Medicine|February 5, 2024
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collectionVanni Benvenga, Aline Cuénod, Srinithi Purushothaman, et al.
Plos One|June 5, 2025
Remote early detection of SARS-CoV-2 infections using a wearable-based algorithm: Results from the COVID-RED study, a prospective randomised single-blinded crossover trialLaura C Zwiers, Timo B Brakenhoff, Brianna M Goodale, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Diagnostics (Basel, Switzerland)|August 23, 2020
EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)Marc Kovac, Lorenz Risch, Sarah Thiel, et al.
Biomed Research International|November 23, 2020
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical PresentationMartin Risch, Myriam Weber, Sarah Thiel, et al.
Clinical Chemistry and Laboratory Medicine|September 1, 2020
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based studyRita Christiane Baron, Lorenz Risch, Myriam Weber, et al.
American Journal of Hypertension|February 27, 2018
Association of 24-Hour Blood Pressure With Urinary Sodium Excretion in Healthy AdultsJan Gerrit van der Stouwe, Cristian Carmeli, Stefanie Aeschbacher, et al.
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Disease Markers|February 3, 2021
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 AntibodiesMyriam C Weber, Martin Risch, Sarah L Thiel, et al.
Iscience|October 21, 2022
Genome-wide analyses identify <i>SCN5A</i> as a susceptibility locus for premature atrial contraction frequencySébastien Thériault, Medea Imboden, Mary L Biggs, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Genome Medicine|February 5, 2024
Historic methicillin-resistant Staphylococcus aureus: expanding current knowledge using molecular epidemiological characterization of a Swiss legacy collectionVanni Benvenga, Aline Cuénod, Srinithi Purushothaman, et al.
Plos One|June 5, 2025
Remote early detection of SARS-CoV-2 infections using a wearable-based algorithm: Results from the COVID-RED study, a prospective randomised single-blinded crossover trialLaura C Zwiers, Timo B Brakenhoff, Brianna M Goodale, et al.
Pageof 12